CBE Pure Solutions
Melbourne, Australia· Est.
Australia’s first small‑scale sterile GMP CMO, delivering end‑to‑end fill‑finish and microbiology services for clinical‑trial and commercial products.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Australia’s first small‑scale sterile GMP CMO, delivering end‑to‑end fill‑finish and microbiology services for clinical‑trial and commercial products.
All therapeutic areas
Technology Platform
GMP‑licensed isolator units for sterile liquid fill‑finish combined with a rapid sterility microbiology platform (SRMM) using the BioMérieux Scan RDI system.
Opportunities
Expanding on‑shore GMP capacity for early‑stage biologics and vaccines across Australia and the Asia‑Pacific, leveraging its rapid microbiology platform to shorten release timelines.
Risk Factors
Scaling production while maintaining strict GMP compliance and competing with larger, established CMOs that have broader global footprints.
Competitive Landscape
CBEPS differentiates itself through small‑batch, on‑shore sterile manufacturing and integrated rapid sterility testing, a niche not widely offered by larger multinational contract manufacturers.